| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |